BCL2 and liver cancer: Recent studies demonstrate that adding an emulsion containing L. rhamnosus NCIMB 8010 and Pediococcus acidilactici NCIMB 8018 to liver cancer cells mitigates insulin resistance induced by free fatty acid accumulation, enhances cell viability, and regulates the Bax/Bcl-2 and caspase axes to improve mitochondrial dysfunction.